Compare Guardant Health Inc. Common Stock (GH) vs Global X Uranium ETF (URA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs Global X Uranium ETF — how do they compare? Guardant Health Inc. Common Stock trades at $169.18 (market cap $22.22B), while Global X Uranium ETF trades at $38.63 (market cap $5.48B). The key difference: Guardant Health Inc. Common Stock is far larger — about 4.1× Global X Uranium ETF's market cap, and Guardant Health Inc. Common Stock is trading nearer its 52-week high, Global X Uranium ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Global X Uranium ETF for 62 Days on average.
| GH | URA | |
|---|---|---|
Market Cap | $22.22B | $5.48B |
Volume | 1,589,453 | 5,287,170 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $187.22 | $61.81 |
52-Week Low | $61.73 | $37.52 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $22.86B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
URA, the Global X Uranium ETF, trades at $39.93, down 4.47% today amid a bearish technical signal. The ETF is positioned in the nuclear energy sector, which is seeing increased attention due to AI-driven power demand and government support. Technical indicators show strong sell signals from moving averages, while oscillators are neutral. Recent news highlights a nuclear renaissance but also notes volatility in uranium equities.
The outlook for URA is mixed, with long-term growth potential from global nuclear expansion and AI energy needs, but near-term risks include commodity price sensitivity and sector volatility. Investors should weigh the ETF's concentrated exposure against broader nuclear infrastructure opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About Global X Uranium ETF
URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.
Read more on URA →
